Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Revolution Medicines Inc shares valued at $400,932 were sold by Anders Jack on Nov 25 ’25. At $74.00 per share, Anders Jack sold 5,418 shares. The insider’s holdings dropped to 110,994 shares worth approximately $8.62 million following the completion of this transaction.
Also, GOLDSMITH MARK A sold 60,000 shares, netting a total of over 4,504,962 in proceeds. Following the sale of shares at $75.08 each, the insider now holds 247,863 shares.
Before that, GOLDSMITH MARK A had sold 6,000 shares from its account. In a trade valued at $450,000, the insider traded Revolution Medicines Inc shares for $75.00 each. Upon closing the transaction, the insider’s holdings decreased to 6,000 shares, worth approximately $5.24 million.
As published in their initiating research note from Wolfe Research on November 18, 2025, Revolution Medicines Inc [RVMD] has been an Outperform and the price target has been revised to $75. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in early November. As of October 21, 2025, Mizuho has initiated its “an Outperform” rating for RVMD.
Analyzing RVMD Stock Performance
On last trading session, Revolution Medicines Inc [NASDAQ: RVMD] rose 3.16% to $77.69. The stock’s lowest price that day was $74.52, but it reached a high of $79.0699 in the same session. During the last five days, there has been a surge of approximately 1.80%. Over the course of the year, Revolution Medicines Inc shares have jumped approximately 34.30%. Shares of the company reached a 52-week high of $79.07 on 12/03/25 and a 52-week low of $29.17 on 04/07/25.
Support And Resistance Levels for Revolution Medicines Inc (RVMD)
According to the 24-hour chart, there is a support level at 75.12, which, if violated, would cause prices to drop to 72.54. In the upper region, resistance lies at 79.67. The next price resistance is at 81.64. RSI (Relative Strength Index) is 79.36 on the 14-day chart, showing overbought technical sentiment.
Is Revolution Medicines Inc subject to short interest?
Stocks of Revolution Medicines Inc saw a sharp steep in short interest on 2025-11-14 dropping by -1.88 million shares to 17.49 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 19.36 million shares. A decline of -10.74% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 7.05 of the overall float, the days-to-cover ratio (short ratio) decline to 7.05.
Which companies own the most shares of Revolution Medicines Inc (RVMD)?
In terms of Revolution Medicines Inc share price expectations, FactSet research, analysts set an average price target of 78.5 in the next 12 months, up nearly 4.24% from the previous closing price of $75.31. Analysts anticipate Revolution Medicines Inc stock to reach 99 by 2025, with the lowest price target being 75. In spite of this, 13 analysts ranked Revolution Medicines Inc stock as Buy at the end of 2025. On September 12, 2025, Raymond James assigned a price target of “a Strong buy” to the stock and resumed coverage with a $72.
